WebThe standard of care for fit multiple myeloma patients is to receive high-dose chemotherapy (HDT) with autologous stem cell rescue — otherwise known as autologous stem cell transplant (ASCT) — after completion of induction therapy. Autologous stem cell transplant can provide significant remission that is both long and deep, extending survival. WebSome small-sized uncontrolled studies demonstrated breast cancer women with poor-prognosis can benefit from high-dose chemotherapy, which prolonged disease-free survival and overall survival. 21,22 The increased dose intensity and total dose of adjuvant chemotherapy can improve the outcomes of breast cancer patients. 23 In addition, the …
Chronic Myelogenous Leukemia Treatment (PDQ®)–Health
Web9 de abr. de 2024 · MRI or PET was recommended, to aid in target definition. The contour of GTV included primary tumor and metastatic lymph nodes. The PTV included 0–5 mm enlargement of GTV. The contour of the PTV cannot stretch into and overlap the margin of the gastrointestinal tract. The prescribed dose of PTV was 42.5–55.0 Gy, in 5–7 fractions. WebTumor lysis syndrome (TLS) is a potential side effect of chemotherapy, particularly high dose induction chemotherapy. TLS occurs in response to the sudden and widespread destruction of cancer cells. shun from saint seiya
Rats can’t vomit. That’s a problem for medicine. - The Atlantic
WebIn Meyler's Side Effects of Drugs (Sixteenth Edition), 2016. Transplant recipients. The maximum tolerated dose of intravenous micafungin in patients undergoing hemopoietic stem cell transplantation has been explored in an open study of increasing doses of 3, 4, 6, or 8 mg/kg/day from 7 days to a maximum of 28 days or until neutropenia resolved … WebAt present, high-dose chemotherapy program must be regarded as a form of clinical investigation. They have no proved advantage over conventional treatment. Future strategies for further development of this approach are outlined in Table 5. The aim of such studies must be a careful definition of drug dose and of the most effective drug … Web30 de mar. de 2024 · INTRODUCTION. Time-to-treatment-failure (TTF) is the interval from initiation of chemotherapy to its premature discontinuation. Since early discontinuation can occur due to various reasons – such as, cancer progression, adverse events, patient choice, or patient death – TTF can be influenced by factors unrelated to chemotherapy efficacy … the outlast trials indir